New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2013
17:08 EDTHSPHospira stock could surge with successful inspection of facility, Barron's says
Hospira's (HSP) Rocky Mount drug manufacturing facility could be inspected by the FDA in the first half of this year. If the facility passes the inspection, it would increase the company's production and allow the company to expand into other markets, according to Barron's. Reference Link
News For HSP From The Last 14 Days
Check below for free stories on HSP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2014
08:12 EDTHSPHospira to obtain financial benefits from possible Danone deal, says Wells Fargo
After multiple media sources reported that Hospira (HSP) is in talks to buy Danone's (DANOY) medical nutrition business in a potential tax inversion deal, Wells Fargo estimates that the deal could be 9%-12% accretive to Hospira's EPS in 2015-2017 if it's an all-stock deal and 20%-22% accretive if it's a 50%/50% cash and stock deal. The firm The firm estimates that Hospira's tax bill would be cut to 21% in 2015 and 19% afterwards, from its current forecast of 24%-26% during those years. The firm thinks the strategic rationale for the deal from Hospira's perspective, however, is less clear. It keeps a Market Perform rating on the stock.
July 27, 2014
15:12 EDTHSP Hospira in talks to acquire Danone medical nutrition business, FT says
French consumer company Danone (DANOY) has been in negotiations to sell its medical nutrition business to Hospira (HSP) in a deal said to value the unit at $5B, says the Financial Times. The deal would also allow for U.S. based Hospira to domicile its tax base in Europe in a tax strategy known as an inversion, added the Financial Times. In prior reports, Nestle (NSRGY) and Fresenius (FMS) have also been mentioned as suitors for the Danone unit. Reference Link
July 23, 2014
10:02 EDTHSPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTHSPDeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:08 EDTHSPHospira initiated with a Hold at Deutsche Bank
Target $53.
July 18, 2014
10:48 EDTHSPHigh option volume stocks
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use